Tamarly Signal - Weekly Brief, September 13-21, 2026
• A GLP-1 drugmaker partnered with Anthropic to use the Claude AI system for developing new medicines, according to a September 18 report from The Wall Street Journal. • Recent funding patterns show AI investment is shifting away from diagnostic breakthroughs toward infrastructure like coverage verification and benefits administration. • This trend indicates that AI is integrating into healthcare through existing regulatory pathways held by pharmaceutical companies rather than creating new ones.
convergences.substack.com![[AI DAILY NEWS RUNDOWN] Hacktron AI Breaches OpenAI with Claude, Anthropic Builds Physical Wet Lab, & Trump’s Military 'AI Force' (Sept 21, 2026)](/_next/image?url=https%3A%2F%2Fsubstackcdn.com%2Fimage%2Ffetch%2F%24s_!xyd-!%2Cw_1200%2Ch_600%2Cc_fill%2Cf_jpg%2Cq_auto%3Agood%2Cfl_progressive%3Asteep%2Cg_auto%2Fhttps%253A%252F%252Fsubstack-post-media.s3.amazonaws.com%252Fpublic%252Fimages%252Fb06fc345-1129-4814-b8fb-676c3d8878cc_3000x3000.jpeg&w=1920&q=85)













